Evidence map›Paper›PMID 32055783›Full record

ReviewChronic diseases and translational medicine2019

Diagnosis and treatment of

Chao Peng, Yi Hu, Zhong-Ming Ge, Quan-Ming Zou, Nong-Hua Lyu

Open access · goldAbstract readReview
In one paragraph

Review in Chronic diseases and translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Effect of Probiotic-Assisted Eradication ofBioMed research international · 2022
    Trial
  2. Nanomechanical Hallmarks ofInternational journal of molecular sciences · 2021
    Trial
  3. Article
  4. Diseases (Basel, Switzerland) · 2024
    Review
  5. Article
  6. [Viable Bacteria Assay ofSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Article
  7. Clinical Dilemmas for the Diagnosis and Treatment ofPediatric gastroenterology, hepatology & nutrition · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Effect and Safety ofInfection and drug resistance · 2022
    Article
  14. Clinical Relevance ofJournal of clinical medicine · 2021
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Chao PengDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nachang, Jiangxi 330000, China.
Yi HuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nachang, Jiangxi 330000, China.
Zhong-Ming GeDivision of Comparative Medicine, The Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Quan-Ming ZouNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400000, China.
Nong-Hua LyuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nachang, Jiangxi 330000, China.
Nanchang University · CNArmy Medical University · CNFirst Affiliated Hospital of Nanchang University · CNMassachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChildrenDiagnosisElderlyHelicobacter pyloriTreatment

Identifiers

PMID32055783
PMCPMC7005112
OpenAlexW2999557322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.